Norris Medicines Ltd — Important, 14-10-2025: Company Update

Norris Medicines Limited has submitted its quarterly compliance certificate regarding share dematerialisation. The company's Registrar and Transfer Agent confirmed that for the quarter ending September 2025, all securities received for dematerialisation were processed correctly, accepted or rejected, and updated with depositories. The corresponding physical certificates were duly mutilated and cancelled, and depositories' names were updated in the register of members within the required timeframe. This ensures accurate record-keeping and smooth transfer of shares, safeguarding investor interests in their electronic holdings.